Researchers from the University of Liverpool, in collaboration with the Instituto de Salud Carlos III and the European Mobile Laboratory, have published two landmark studies in The Journal of Infectious Diseases that utilize artificial intelligence to decode the host immune response to Ebola virus disease. Led by Professor Julian Hiscox and including field researcher Dr. Isabel Garcia Dorival, the studies analyze blood samples collected during the 2013–2016 West Africa epidemic, providing critical insights amid an ongoing outbreak in the Democratic Republic of the Congo. Current clinical triage relies heavily on viral load, a metric that fails to consistently explain divergent patient outcomes. By applying machine-learning algorithms to host transcriptomic data, the first study identified distinct immune biomarkers that differentiate survivors from fatal cases. When integrated with viral load measurements, these host markers substantially improve the accuracy of clinical prognosis, offering a more robust diagnostic framework for future outbreak response. The second investigation examines how age and sex modulate immune defense mechanisms. Survivors consistently exhibited a more controlled immune response, though its manifestation varied by demographic. Notably, genes governing lymphocyte differentiation declined with age in fatal cases but increased with age in survivors, underscoring that immunological trajectories are heavily influenced by host biology rather than viral quantity alone. These findings establish that precise Ebola management requires moving beyond virological metrics to incorporate host-specific genetic and immunological profiles. Professor Hiscox emphasized that understanding host-pathogen interactions will directly inform the development of targeted diagnostics and therapeutic interventions. The research has garnered endorsement from the U.S. Food and Drug Administration, with Chief Scientist Dr. Steven Kozlowski noting that global collaborative efforts are essential for advancing high-consequence infectious disease preparedness, refining patient management protocols, and strengthening public health infrastructure. The integration of artificial intelligence with clinical virology marks a significant shift toward personalized outbreak response, enabling healthcare systems to predict disease severity with greater precision and allocate resources more effectively during emerging Ebola crises.